Cite
HARVARD Citation
Hu, B. et al. (2019). High-risk myeloma and minimal residual disease postautologous-HSCT predict worse outcomes. Leukemia & lymphoma. 60 (2), pp. 442-452. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Hu, B. et al. (2019). High-risk myeloma and minimal residual disease postautologous-HSCT predict worse outcomes. Leukemia & lymphoma. 60 (2), pp. 442-452. [Online].